Apricitabine is an effective and tolerable treatment for HIV-1 infection

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1547, 2006-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multiple-Dose Pharmacokinetics of Apricitabine, a Novel Nucleoside Reverse Transcriptase Inhibitor, in Patients with HIV-1 Infection

By Cahn Pedro

Clinical Drug Investigation, Vol. 28, Iss. 2, 2008-01 ,pp. : 129-138

Adis International

Access to resources Recommend Favorite

Favourable safety profile for apricitabine in HIV-1 infections

Inpharma, Vol. 1, Iss. 1652, 2008-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Structured treatment interruption strategy effective for HIV infection

Inpharma, Vol. 1, Iss. 1560, 2006-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Darunavir: In the Treatment of HIV-1 Infection

By Fenton Caroline Perry Caroline M.

Drugs, Vol. 67, Iss. 18, 2007-01 ,pp. : 2791-2801

Adis International

Access to resources Recommend Favorite

Raltegravir: In Treatment-Naive Patients with HIV-1 Infection

By Croxtall Jamie D. Scott Lesley J.

Drugs, Vol. 70, Iss. 5, 2010-03 ,pp. : 631-642

Adis International

Access to resources Recommend Favorite